Lion Street Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $946K | Sell |
9,058
-489
| -5% | -$51K | 0.29% | 80 |
|
|
2025
Q1 | $1.11M | Sell |
9,547
-52
| -0.5% | -$6.07K | 0.35% | 60 |
|
|
2024
Q4 | $812K | Buy |
9,599
+1,344
| +16% | +$114K | 0.26% | 86 |
|
|
2024
Q3 | $742K | Sell |
8,255
-60
| -0.7% | -$5.39K | 0.26% | 84 |
|
|
2024
Q2 | $669K | Sell |
8,315
-3,617
| -30% | -$291K | 0.25% | 88 |
|
|
2024
Q1 | $950K | Hold |
11,932
| – | – | 0.39% | 51 |
|
|
2023
Q4 | $950K | Sell |
11,932
-2,350
| -16% | -$187K | 0.39% | 51 |
|
|
2023
Q3 | $998K | Sell |
14,282
-620
| -4% | -$43.3K | 0.33% | 59 |
|
|
2023
Q2 | $574K | Sell |
14,902
-230
| -2% | -$8.86K | 0.19% | 99 |
|
|
2023
Q1 | $933K | Buy |
15,132
+1,955
| +15% | +$121K | 0.29% | 59 |
|
|
2022
Q4 | $507K | Sell |
13,177
-135
| -1% | -$5.2K | 0.27% | 61 |
|
|
2022
Q3 | $590K | Buy |
13,312
+135
| +1% | +$5.98K | 0.29% | 45 |
|
|
2022
Q2 | $513K | Buy |
13,177
+75
| +0.6% | +$2.92K | 0.27% | 60 |
|
|
2022
Q1 | $538K | Sell |
13,102
-75
| -0.6% | -$3.08K | 0.28% | 57 |
|
|
2021
Q4 | $503K | Hold |
13,177
| – | – | 0.25% | 64 |
|
|
2021
Q3 | $433K | Buy |
+13,177
| New | +$433K | 0.23% | 70 |
|